african/antifungal

Kiungo kimehifadhiwa kwenye clipboard

Chagua aina ya aina

15 matokeo

Vectors derived from South African Arbovirus No. 86

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The present invention relates to alphavirus vectors and methods of making and administering the same, in particular, the present invention relates to alphavirus vectors derived from South African Arbovirus No. 86, and methods of making an administering the same. BACKGROUND OF

Preventive and therapeutic use of polypeptides from African Swine virus as vaccines

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The present invention generally relates to the use of selected polypeptides from African Swine virus for the prevention and therapy of African Swine infections as well as other infections, including immune deficiencies in mammals and humans. BACKGROUND OF THE INVENTION African

Nucleic acids encoding modified South African HIV-1 subtype C gag proteins

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND TO THE INVENTION This invention relates to a process for the selection of HIV-1 subtype (clade) C isolates, selected HIV-1 subtype C isolates, their genes and modifications and derivatives thereof for use in prophylactic and therapeutic vaccines to produce proteins and polypeptides for

Therapeutic dressing having mineral components

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

This invention relates to therapeutic dressings, in particular dressings for treating burns. Skin injuries involving inflammation, particularly burn wounds, have been treated in a number of ways. In the so-called exposure method, the burn wound is left open without any covering, dressing or bandage.

Alternative G-coupled receptors associated with retroviral entry into cells, methods of identifying the same, and diagnostic and therapeutic uses thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

TECHNICAL FIELD OF THE INVENTION The present invention relates generally to the infection of target cells by HIV-1, HIV-2, and SIV and more particularly to agents identified herein that mediate the entry of retroviruses into such target cells, and to the diagnostic and therapeutic uses to which such

G-coupled receptors associated with retroviral entry into cells, and therapeutic uses thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

TECHNICAL FIELD OF THE INVENTION The present invention relates generally to the infection of target cells by HIV-1, HIV-2 and SIV and more particularly to agents identified herein that mediate the entry of retroviruses into such target cells, and to the diagnostic and therapeutic uses to which such

Semi-synthetic small molecules for the treatment parasitic disease

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION Small molecule therapeutics for the treatment of parasitic diseases, in particular, semi-synthetic derivatives of the fugally-derived natural product merulin A for the treatment of African Sleeping Sickness. BACKGROUND Human African Trypanosomiasis (HAT) is transmitted by the

Methods for making and using novel semi-synthetic small molecules for the treatment parasitic disease

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION Small molecule therapeutics for the treatment of parasitic diseases, in particular, semi-synthetic derivatives of the fungally-derived natural compound Merulin A for the treatment of African Sleeping Sickness. BACKGROUND Human African Trypanosomiasis (HAT) is transmitted by

Compounds exhibiting an antibiotic activity

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

This application is a 371 of PCT/EP00/04089 filed 6 May 2000, which claims foreign priority benefit of the filing date under 35 U.S.C. 119 of Germany patent application No. 19921027.6 filed 7 May 1999. The present invention relates to compounds having antibiotic activity which are obtained from body

Ubiquitin conjugating enzymes 7, 8 and 9

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptides of the present invention are Ubiquitin

Ubiquitin conjugating enzymes 8 and 9

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Ubiquitin conjugating enzymes 7,8 and 9

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

This application is entitled to the benefits of 35 U.S.C. .sctn.120 for priority based on PCT/US95/01250, filed 31 Jan. 1995. This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the

Ubiquitin conjugating enzymes 8 and 9

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

This application is entitled to the benefits of 35 USC .sctn.120 for priority based on PCT/US95/01250, filed 31 Jan. 1995. This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the

Medicinal composition containing benzo[a]phenoxazine compound as the active ingredient for prevention or treatment of protozoal disease

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

TECHNICAL FIELD The present invention relates to a medicinal composition containing as an active ingredient a benzo[a]phenoxazine compound for prevention or treatment and to a benzo[a]phenoxanzine compound. The medicinal composition of the present invention is useful for treatment and/or treatment

Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION Myocardial infarction (MI) and Acute Coronary Syndrome (ACS), e.g., unstable angina, non-ST-elevation myocardial infarction (NSTEMI) or ST-elevation myocardial infarction (STEMI), are the leading causes of hospital admissions in industrialized countries. Cardiovascular

Jiunge na ukurasa
wetu wa facebook

Herbal & Natural Medicine

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

Inafanya kazi katika lugha 55
Uponyaji wa mitishamba unaungwa mkono na sayansi
Kutambua mimea kwa picha
Ramani ya GPS inayoshirikiana
Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
Tafuta mimea ya dawa na athari zao
Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa